Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT02676050
Eligibility Criteria:
INCLUSION CRITERIA FOR COHORT 1 • Patients undergoing cardiothoracic surgery for resection of lung cancer
INCLUSION CRITERIA FOR COHORT 2
• Patients with inoperable stage 3 or 4 lung cancer
INCLUSION CRITERIA FOR BOTH COHORTS
* ≥ 16 years
* Provision of informed consent from the patient prior to any study related procedures.
* Normal electrocardiogram (ECG)
* Forced Expiratory Volume (FEV1) \>1L
* Thoracic CT scan taken in the last 20 weeks
* Attending consultant permission for bronchoscopy
* Readily accessible target areas with bronchoscopy and FE
EXCLUSION CRITERIA
* Refusal for participation by attending consultant
* Unsuitable for bronchoscopy
* Any history of anaphylaxis
* Significant coagulopathy, which causes bronchoscopy to be unsuitable, as determined by clinical co-investigator or the participant's attending consultant, using information which is routinely available
* Myocardial infarction in the preceding four weeks
* Women who are pregnant or are breastfeeding
* Receiving drugs that cause increased autofluorescence in the lung, specifically amiodorane and methotrexate
* Oxygen saturation \<92% breathing room air
* Platelet count \< 50 x 109/L
* Bleeding diathesis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT02676050
Study Brief:
Protocol Section:
NCT02676050